According to the new market research report "Allergy Diagnostics Market by Products (Assay Kits, Immunoassay & Elisa Analyzers, Luminometers, Services), Allergens (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End Users (Hospital, Diagnostic Laboratory) - Global Forecast to 2022", published by MarketsandMarkets™

The high incidence of allergic diseases is one of the major factors driving the growth of this market. The rising environmental pollution levels and the growing need for relatively faster, accurate, and high-throughput technologies for allergy diagnostics are the major factors supporting the growth of this market.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=232871701

Assay kits are estimated to dominate the market in 2017

On the basis of product & service, the Allergy Diagnostics Market is segmented into assay kits, instruments, and services. The instruments segment is further subsegmented into immunoassay analyzers, luminometers, ELISA analyzers, and other instruments. The assay kits segment is expected to dominate the global Allergy Diagnostics Market in 2017. Efficient performance, reliability, and great level of precision are key drivers increasing the demand for assay kits.

Browse and in-depth TOC on "Allergy Diagnostics Market"
105 - Tables
32 - Figures
149 - Pages

Inhaled allergens are estimated to command the largest market share in 2017

On the basis of allergens, the Allergy Diagnostics Market is segmented into inhaled allergens, food allergens, drug allergens, and other allergens. In 2017, the inhaled allergens segment is expected to account for the largest share of the Allergy Diagnostics Market. Increasing environmental pollution is one of the major factors driving the growth of this segment.

North America estimated to account for the major market share in 2017

Based on region, the Allergy Diagnostics Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2017, North America is expected to command the largest share of the Allergy Diagnostics Market. The large share of this segment can primarily be attributed to the increasing healthcare expenditure, coverage of allergy diagnostics tests in medical insurance, and the strong presence of players in this region.

Read a Press-Release on “Allergy Diagnostics Market”:
https://www.marketsandmarkets.com/PressReleases/allergy-diagnostics.asp

Key players in the Allergy Diagnostics Market include Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), Danaher Corporation (US), Omega Diagnostics Group PLC (UK), Hitachi Chemical Co., Ltd. (Japan), bioMérieux SA (France), Stallergenes Greer (UK), HOB Biotech Group Suzhou Co., Ltd. (China), HYCOR Biomedical (US), Lincoln Diagnostics, Inc. (US), EUROIMMUN AG (Germany), INDOOR Biotechnologies, Inc. (US), DR. FOOKE - Achterrath Laboratorien GmbH (Germany), R-Biopharm AG (Germany), GA Generic Assays GmbH (Germany), Tecan Trading AG (Switzerland)